# US 2012/0083690 A1 · System and method for electromagnetic imaging and therapeutics using specialized nanoparticles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083690 A1
- Document ID: US20120083690A1
- Status: Published application
- Kind: A1
- Application number: 13/252,272
- Filed: 2011-10-04
- Published: 2012-04-05
- Earliest claimed: 2010-10-04
- Inventors: Serguei Y. SEMENOV
- Web page: https://patentgrep.com/patent/US20120083690A1

## CPC

- A61B 5/4839: {combined with drug delivery}
- A61B 5/0515: Magnetic particle imaging
- A61B 5/384: Recording apparatus or displays specially adapted therefor
- A61B 5/389: Electromyography [EMG]
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- A61B 5/7225: {Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316)}
- A61B 2576/026: for the brain
- A61N 1/406: {using implantable thermoseeds or injected particles for localized hyperthermia (preparations of seeds and particles A61K41/0052)}
- G16H 30/40: for processing medical images, e.g. editing
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Various systems and methods utilizing composite nanoparticles or other specialized nanoparticles in the context of electromagnetic tomography are described. A method for electromagnetic imaging includes imaging a biological tissue via an electromagnetic tomography system, recording electrical activity of the biological tissue via a biomedical electrical recording system, and correlating dielectric properties of the biological tissue with an electrical signal recorded by the biomedical electrical recording system. A method for electromagnetic imaging and therapeutics using composite nanoparticles includes imaging a biological tissue, via an electromagnetic tomography system, using a material in the composite nanoparticles, implementing a therapy, via a therapeutic application system, using a material in the composite nanoparticles, wherein the implementation is carried out at least partly on the basis of information received from the electromagnetic tomography system, assessing an effect of the therapy, and controlling further implementation of the therapy based on the assessment.

## Claims

### Claim at position 1

-47. (canceled)

### Claim 48

A system for electromagnetic imaging and therapeutics using composite nanoparticles, comprising:
(a) an electromagnetic tomography system adapted to image a biological tissue via a material in the composite nanoparticles;
(b) a therapeutic application system adapted to implement a therapy, via a material in the composite nanoparticles, at least partly on the basis of information received from the electromagnetic tomography system; and
(c) a control system adapted to assess an effect of the therapy and to control further implementation of the therapy based on the assessment.

### Claim 49 (depends on 48)

The system of claim 48, wherein the electromagnetic tomography system is adapted to image the biological tissue via a first material in the composite nanoparticles, and wherein the therapeutic application system is adapted to implement the therapy via a second material in the composite nanoparticles.

### Claim 50 (depends on 49)

The system of claim 49, wherein the first material in the composite nanoparticles includes a ferroelectric material.

### Claim 51 (depends on 49)

The system of claim 49, wherein the second material in the composite nanoparticles includes a magnetic material.

### Claim 52 (depends on 49)

The system of claim 49, wherein the therapy utilizes an electrical mechanism.

### Claim 53 (depends on 49)

The system of claim 49, wherein the therapy utilizes a thermogenic mechanism.

### Claim 54 (depends on 49)

The system of claim 49, wherein the therapeutic application system includes antennas disposed at points around the biological tissue.

### Claim 55 (depends on 49)

The system of claim 49, wherein the therapeutic application system includes one or more coil arranged around the biological tissue.

### Claim 56 (depends on 48)

The system of claim 48, wherein the nanoparticle material via which the electromagnetic tomography system is adapted to image the biological tissue is the same nanoparticle material via which the therapeutic application system is adapted to implement the therapy.

### Claim 57

A method for electromagnetic imaging and therapeutics using composite nanoparticles, comprising:
(a) imaging a biological tissue, via an electromagnetic tomography system, using a material in the composite nanoparticles;
(b) implementing a therapy, via a therapeutic application system, using a material in the composite nanoparticles, wherein the implementation is carried out at least partly on the basis of information received from the electromagnetic tomography system;
(c) assessing an effect of the therapy; and
(d) controlling further implementation of the therapy based on the assessment.

### Claim 58 (depends on 57)

The system of claim 57, wherein the step of imaging the biological tissue uses a first material in the composite nanoparticles, and wherein the step of implementing the therapy uses a second material in the composite nanoparticles.

### Claim 59 (depends on 58)

The method of claim 58, wherein the first material in the composite nanoparticles includes a ferroelectric material.

### Claim 60 (depends on 58)

The method of claim 58, wherein the second material in the composite nanoparticles includes a magnetic material.

### Claim 61 (depends on 58)

The method of claim 58, wherein implementing the therapy includes utilizing an electrical mechanism.

### Claim 62 (depends on 58)

The method of claim 58, wherein implementing the therapy includes utilizing a thermogenic mechanism.

### Claim 63 (depends on 58)

The method of claim 58, wherein implementing the therapy includes disrupting or opening pores in the cellular membrane of targeted cells.

### Claim 64 (depends on 58)

The method of claim 58, wherein implementing the therapy includes disrupting or opening pores in the shell of the nanoparticles to release a drug therefrom.

### Claim 65 (depends on 57)

The method of claim 57, wherein the step of imaging the biological tissue and the step of implementing the therapy use the same material in the composite nanoparticles.
